"As a purely speculative view, one wonders what the broader implications of a treatment like this can be. If it can be used to improve cognitive function in those that have suffered brain injuries, what can the drug do for a ‘healthy’ brain. Could it be used as a (hopefully legal) performance enhancing drug where people like you and I could improve cognitive function, memory and general brain health? That would make this market pretty far reaching."
This is something I never considered... I don't have the technical expertise, but does anyone on here who does think this is a possibility?
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren Investor Presentation, 11 January 2016
NEU
neuren pharmaceuticals limited
Add to My Watchlist
9.33%
!
$13.71

Ann: Neuren Investor Presentation, 11 January 2016, page-19
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.71 |
Change
1.170(9.33%) |
Mkt cap ! $1.730B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $9.345M | 682.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4 | $13.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.71 | 129 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 163 | 13.710 |
5 | 217 | 13.700 |
7 | 767 | 13.690 |
6 | 1314 | 13.680 |
4 | 1473 | 13.670 |
Price($) | Vol. | No. |
---|---|---|
13.730 | 190 | 4 |
13.740 | 419 | 4 |
13.750 | 1775 | 8 |
13.760 | 1435 | 10 |
13.770 | 1276 | 8 |
Last trade - 12.22pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online